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Abstract
Background: Invasive intensive care unit (ICU) treatments for patients with advanced medical illnesses and poor prognoses
may prolong suffering with minimal benefit. Unfortunately, the quality of care planning and communication between clinicians
and critically ill patients and their families in these situations are highly variable, frequently leading to overutilization of invasive
ICU treatments. Time-limited trials (TLTs) are agreements between the clinicians and the patients and decision makers to use
certain medical therapies over defined periods of time and to evaluate whether patients improve or worsen according to
predetermined clinical parameters. For patients with advanced medical illnesses receiving aggressive ICU treatments, TLTs can
promote effective dialogue, develop consensus in decision making, and set rational boundaries to treatments based on patients’
goals of care.
Objective: The aim of this study will be to examine whether a multicomponent quality-improvement strategy that uses protocoled
TLTs as the default ICU care-planning approach for critically ill patients with advanced medical illnesses will decrease duration
and intensity of nonbeneficial ICU care without changing hospital mortality.
Methods: This study will be conducted in medical ICUs of three public teaching hospitals in Los Angeles County. In Aim 1,
we will conduct focus groups and semistructured interviews with key stakeholders to identify facilitators and barriers to
implementing TLTs among ICU patients with advanced medical illnesses. In Aim 2, we will train clinicians to use protocol-enhanced
TLTs as the default communication and care-planning approach in patients with advanced medical illnesses who receive invasive
ICU treatments. Eligible patients will be those who the treating ICU physicians consider to be at high risk for nonbeneficial
treatments according to guidelines from the Society of Critical Care Medicine. ICU physicians will be trained to use the TLT
protocol through a curriculum of didactic lectures, case discussions, and simulations utilizing actors as family members in
role-playing scenarios. Family meetings will be scheduled by trained care managers. The improvement strategy will be implemented
sequentially in the three participating hospitals, and outcomes will be evaluated using a before-and-after study design. Key process
outcomes will include frequency, timing, and content of family meetings. The primary clinical outcome will be ICU length of
stay. Secondary outcomes will include hospital length of stay, days receiving life-sustaining treatments (eg, mechanical ventilation,
vasopressors, and renal replacement therapy), number of attempts at cardiopulmonary resuscitation, frequency of invasive ICU
procedures, and disposition from hospitalization.
Results: The study began in August 2017. The implementation of interventions and data collection were completed at two of
the three hospitals. As of September 2019, the study was at the postintervention stage at the third hospital. We have completed
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focus groups with physicians at each medical center (N=29) and interviews of family members and surrogate decision makers
(N=18). The study is expected to be completed in the first quarter of 2020, and results are expected to be available in mid-2020.
Conclusions: The successful completion of the aims in this proposal may identify a systematic approach to improve communication
and shared decision making and to reduce nonbeneficial invasive treatments for ICU patients with advanced medical illnesses.
International Registered Report Identifier (IRRID): DERR1-10.2196/16301
(JMIR Res Protoc 2019;8(11):e16301)  doi: 10.2196/16301
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Introduction
Background
Clinical Significance of Intensive Care Unit
Overutilization Among Patients With Advanced Medical
Illnesses
In the United States, 1 in 5 people die using intensive care unit
(ICU) services, frequently receiving invasive treatments despite
minimal anticipated benefit [1,2]. Investigators in our research
group found that 20% of ICU patients in the University of
California Los Angeles (UCLA) health care system were
perceived by physicians to be receiving futile care [3]. A recent
study from our research group [4] and previous work from others
[5-7] also showed that hospitals that utilize ICUs more
frequently were more likely to perform invasive procedures and
have higher costs with no improvement in hospital mortality.
Interestingly, most patients with advanced medical illnesses
prefer not to receive such aggressive care at the end of life
[1,8-12] but ICU care in this population is increasing [2,13].
This trend represents an important health care problem; a
multicenter controlled study estimated that patients with
advanced medical illnesses who died in ICUs spent an average
of 8 days in undesirable states, such as being comatose or
receiving mechanical ventilation [14]. Among conscious ICU
patients who died, 50% experienced significant pain for more
than half the time during the final week of life [14]. Furthermore,
terminal hospitalizations account for 7.5% of total inpatient
costs in the United States, with ICU care accounting for nearly
80% of these costs [1,15]. Overall, these findings show that
optimizing ICU utilization among patients with advanced
medical illnesses is an opportunity to improve the quality and
efficiency of care in this high-risk, high-cost population.
Intensive Care Unit Overutilization in the Los Angeles
County Department of Health Services
Like many health care systems, ICU overutilization is highly
prevalent in the hospitals of the Los Angeles County (LAC)
Department of Health Services (DHS), the second-largest public
health care system in the United States. A recent study from
our group showed that among 808 medical ICU patients at
Harbor-UCLA Medical Center (HUMC), over 20% had reduced
likelihoods of benefit from ICU care due to advanced medical
illnesses, such as advanced dementia and metastatic cancer (see
Table 1) [16]. Of these patients, 86% died or were discharged
in severely compromised health states and only 6% were
discharged home. This subset of patients is at the highest risk
to have invasive treatments that prolong suffering without
improving outcomes. As such, we focus this proposal on
improving ICU utilization on these critically ill patients with
advanced medical illnesses.
In order to understand why patients with advanced medical
illnesses received ICU care so frequently, we conducted
semistructured interviews of ICU physicians and nurses at LAC
DHS hospitals. Key themes that emerged from these interviews
were that health care providers do not comprehensively discuss
prognoses, risks and benefits, and patient preferences for ICU
treatments, which lead to inaccurate expectations from ICU care
and unrealistic fears of prematurely forgoing potentially
beneficial treatments. Barriers to effective shared decision
making included (1) underappreciation of the value of ICU care
planning, (2) lack of institutional standards and tools for ICU
care planning, and (3) difficulty in scheduling meetings between
providers and families.
Table 1. Priority levels of medical intensive care unit (ICU) admissions at Harbor-University of California Los Angeles Medical Center.
Percentage, %DescriptionPriority
46.9Critically ill, needing intensive treatment and monitoring that cannot be provided outside of ICUs1
23.4Not critically ill, but requiring close monitoring and potentially immediate intervention2
20.9Critically ill, but reduced likelihood of recovery because of underlying diseases or severity of acute illness3
8.8Not appropriate for ICU; equivalent outcomes achievable with non-ICU care4
Facilitating Shared Decision Making Using
Time-Limited Trials
Prior work has shown that developing ICU interventions that
change physician behaviors, facilitate communication between
providers and families, and improve patient care is challenging
[14,17,18]. A large multicenter clinical trial—the Study to
Understand Prognoses and Preferences for Outcomes and Risks
of Treatment (SUPPORT)—did not improve the quality of
end-of-life care by providing physicians with patients’
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prognostic information and nurse-facilitated advanced-care
planning [14]. A hypothesis for why SUPPORT failed to change
outcomes is that it did not use a multifaceted, systems approach
to changing physicians’ behaviors [19,20]. Furthermore, even
when prognoses are understood and risks and benefits of ICU
care are discussed, it is likely that clinicians, patients, and
families frequently remain uncertain about the appropriateness
of ICU care [21-23]. In such situations, the default decision in
most ICUs is to pursue aggressive ICU treatments, often without
reassessment of that decision [24].
For patients with advanced illnesses, this approach places them
at risk for prolonged suffering with minimal anticipated benefit
[3,4]. Time-limited trials (TLTs) are agreements between the
clinicians and the patients and decision makers to use certain
medical therapies over a defined period of time and evaluate
whether patients improve or worsen according to predetermined
clinical parameters [24]. TLTs involve detailed discussions of
patients’ preferences for care, prognosis, and what would
constitute clinical improvement based on patients’ values and
preferences. Follow-up meetings are held to see if patients
improve or worsen according to predetermined clinical
parameters and next steps in care are negotiated based on these
results [24]. TLTs promote regular structured dialogue between
providers and patients and their families, promote consensus in
decision making through iterative assessments of clinical
trajectory, and set rational boundaries to treatments based on
patients’ goals of care. TLTs have been used effectively for
outpatient advanced-care planning in patients with end-stage
kidney disease, stroke, cancer, and chronic obstructive
pulmonary disease [25-30]. However, to our knowledge there
have been no studies that examined their effectiveness in ICU
patients. Schenker et al examined audio-recordings of ICU
family meetings for 72 patients at high risk for death or severe
impairment and found that TLTs were offered only 13% of the
time [31]. When TLTs were offered, clinicians frequently did
not discuss key elements, such as outcomes used to determine
improvement, worsening, or possible next steps after the trial
[31].
In summary, nonbeneficial treatments are frequently delivered
in medical ICUs to patients with advanced medical illnesses.
Although the appropriateness of ICU care in this population is
subject to varying opinions, there is general consensus that
intensity of ICU treatments should align with patients’
prognoses, preferences, and values [32]. Previous studies suggest
that most patients with advanced medical illnesses, when
informed of their therapeutic options, would forgo invasive
treatments and would prefer palliative approaches [1,8-12].
Unfortunately, structured care planning between clinicians and
critically ill patients and their families is infrequent [33,34].
TLTs are a promising, but underutilized, care-planning approach
for ICU patients with advanced medical illnesses. An
intervention utilizing TLTs as a default care-planning approach
for ICU patients with advanced medical illnesses has the
potential to address key barriers to shared decision making
identified in our preliminary studies [35]. However, given the
paucity of studies on their use in critically ill patients and the
complexity of ICU communication, input from key stakeholders
on how best to implement TLTs in this group is crucial.
Objectives
Overview
The objective of this proposal is to test an intervention that seeks
to reduce invasive and nonbeneficial ICU treatments by
improving communication between providers, surrogate decision
makers, and critically ill patients with advanced medical
illnesses. We propose to implement an intervention that
facilitates communication and shared decision making between
providers and patients and their families by using protocoled
TLTs for ICU patients with advanced medical illnesses who
receive aggressive care (see Figure 1).
Figure 1. Implementation strategy for time-limited trials. ICU: intensive care unit.
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We hypothesize that a multicomponent quality-improvement
intervention, informed by stakeholder input and that uses
protocoled TLTs as the default ICU care-planning approach for
critically ill patients with advanced medical illnesses, will
decrease the duration and intensity of nonbeneficial ICU care
without changing hospital mortality. We will examine our
hypothesis with the specific aims discussed in the following
sections.
Aim 1
Aim 1 consists of identifying barriers and facilitators to
performing TLTs in ICU patients with advanced medical
illnesses using focus groups of physicians and semistructured
interviews of patients and their families.
Aim 2
Aim 2 consists of examining whether a multicomponent
quality-improvement intervention using TLTs as the default
care-planning approach for ICU patients with advanced medical
illnesses reduces duration and intensity of nonbeneficial ICU
treatments
Methods
Overview
This proposal will be conducted in the medical ICUs of three
public hospitals in LAC DHS: HUMC, Olive View Medical
Center (OVMC), and Los Angeles County-University of
Southern California (LAC-USC) Medical Center. We will
implement the aims sequentially across the medical centers.
The sequential implementation strategy will be used to identify
ways to improve training and uptake of the interventions with
each iteration. For Aim 1, we will conduct focus groups and
interviews with key stakeholders to identify facilitators and
barriers to implementing TLTs among ICU patients with
advanced medical illnesses. This will be performed prior to
implementing quality-improvement interventions in Aim 2 (see
Multimedia Appendix 1). The information obtained from these
qualitative evaluations will be used to enhance our
implementation strategy for Aim 2, in which we will examine
the effectiveness of our intervention using a before-and-after
study design (see Multimedia Appendix 1).
Aim 1
Rationale and Overview
In the first phase of the proposed study, we will conduct focus
groups with ICU physicians and interviews with patients and/or
surrogate decision makers to explore attitudes toward ICU care
among patients with advanced medical illnesses and strategies
to optimally implement TLTs. We anticipate that themes from
these sessions will include perceived barriers to conducting
family meetings, knowledge and skill deficits among clinicians
in conducting meetings, clinical outcomes most effective in
decision making, optimal timing and frequency of meetings,
optimal duration of TLTs, and communicating sensitive medical
topics to lay populations.
Experimental Approach
Structure of Focus Groups With Intensive Care Unit
Physicians
In-person focus groups with medical ICU physicians will be
conducted at HUMC, OVMC, and LAC-USC Medical Center.
We will invite all ICU attendings and fellows from each
institution; we anticipate that 10-30 people will be invited and
that 6-15 will participate per institution. Informed consent will
be obtained for audio-recording. The meetings will be held at
each medical center, will last approximately 90 minutes, and
will be led by two of the study investigators.
Content of Focus Groups With Intensive Care Unit
Physicians
Moderators will lead discussions in each group. Discussions
will begin with an explanation of the risks and benefits of
aggressive ICU care for patients with advanced medical illnesses
and of the goal of delivering care that aligns with patients’
values and preferences. We will explain the concept of TLTs
and elicit responses to a prespecified set of open-ended
questions.
Sample questions include the following: (1) How are decisions
regarding ICU care currently made? (2) Do you believe that
TLTs are appropriate interventions? Why or why not? (3) What
information is needed to effectively make decisions about
continuing aggressive ICU care? (4) What is the best way to
communicate that information? (5) Should care providers make
recommendations regarding the next steps in care after TLTs?
(6) What are barriers to having meetings with patients and their
families? (7) What information do you typically provide in
family meetings? (8) How do you feel about using a protocol
and checklist during family meetings? (9) How comfortable are
you with making recommendations for end-of-life care? and
(10) How much variability do you perceive between physicians
regarding prognoses and goals of care?
Structure of Semistructured Interviews With Patients and
Surrogate Decision Makers
In-person interviews with patients and/or surrogate decision
makers will be conducted at HUMC, OVMC, and LAC-USC
Medical Center. We will invite English-speaking patients or
family members and surrogate decision makers who are
available to participate in interviews; we anticipate that that 20
people will be invited and that 10 will participate per institution.
Patients and family members will be invited for interviews after
at least 72 hours of ICU hospitalization to provide adequate
opportunities for communication and care planning with ICU
clinicians. Informed consent will be obtained for
audio-recording. The interviews will be held at each medical
center, will last approximately 45 minutes, and will be led by
one of the study investigators.
Content of Semistructured Interviews With Patients and
Surrogate Decision Makers
An investigator will lead semistructured interviews of patients
and/or family members, which will explore decision making in
the ICU. We will explore factors that played key roles in
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decision making during ICU hospitalization with a prespecified
set of open-ended questions.
Sample questions will include the following: (1) Describe the
most difficult decision you had to make during this
hospitalization, (2) What decision did you make and how did
you come to that decision? (3) What did the ICU care providers
do that made that decision harder or easier? (4) What clinical
events resonated with you regarding whether you or your family
member was improving or worsening? (5) What other factors
besides those discussed in family meetings affect your decision
regarding ICU care? (6) How often were you confused about
information that was presented to you during hospitalization?
(7) What information was difficult to understand and why? and
(8) What can the care providers do to better support you during
this time?
Analysis of Focus Groups and Interviews
Analysis of data from focus groups and interviews will be
descriptive, summarizing the range of issues that ICU
physicians, patients, and surrogate decision makers discuss.
Using the audio-recordings and moderators’ notes, content
analysis of the group discussions and interviews will be
performed to systematically define themes, emphasizing those
that represent facilitators and barriers to implementation of our
intervention [36-39]. These themes will be used to modify the
implementation of the quality-improvement intervention in Aim
2.
Aim 2
Rationale and Overview
In the second phase of the proposed study, we will implement
an intervention that facilitates family meetings using serial TLTs
as the default care-planning approach for ICU patients with
advanced medical illnesses. The multicomponent intervention
is based on the capability, opportunity, motivation to perform
a behavior (COM-B) framework by Michie and colleagues
[40-42]; the intervention will address barriers identified in our
preliminary studies that inhibit capabilities, opportunities, and
motivation for effective shared decision making (see Figure 2).
Figure 2. Conceptual framework for interventions. EHR: electronic health record; ICU: intensive care unit.
Experimental Approach
Study Population
Patients with a low likelihood of benefitting from ICU care due
to advanced medical illnesses will be identified by assigning
patients to priority levels from the Society of Critical Care
Medicine guidelines for ICU admissions (see Table 1) [43-45].
This system prioritizes ICU admissions based on the projected
likelihood of benefit. For this proposal, we will train all ICU
physicians—attendings and fellows—to perform daily
priority-level assessments for ICU patients. We have previously
published our experience with training ICU teams to classify
patients using this system [16]. Each day, case managers will
ask ICU physicians to assign priority levels to each patient after
ICU rounds. Our intervention will be implemented on all new
ICU admissions who are assigned to priority levels 3 or 4. We
will exclude patients who were assigned to different priority
levels on admission but who are assigned to priority levels 3 or
4 during their ICU stay. If patients cannot communicate for
themselves and do not have surrogate decision makers, they
will be excluded.
Setting and Study Design
The study will be conducted in medical ICUs of three LAC
DHS hospitals using a before-and-after study design. The study
will be conducted sequentially among the three hospitals to
allow investigators to modify and improve the implementation
strategy over the course of the study based on clinician feedback
(see Multimedia Appendix 1). For each hospital, we will collect
preintervention data during the first 4 months and examine
outcomes for a 4-month period after implementing the study
intervention (see Multimedia Appendix 1). There are 52 medical
ICU beds among the three hospitals. We anticipate that 960
patients will be admitted and screened in both the pre- and
postintervention periods across the three medical ICUs. Based
on our preliminary data, we estimate that 15% will be priority
3 and 4 patients who are candidates for intervention and 10%
will be excluded due to lack of surrogate decision makers. As
such, we estimate studying 130 patients during each 4-month
period. Using alpha=.05 (two-sided), beta=.20 (80% power),
and mean ICU stay of 6.5 days (SD 3.7) from our previous study
[16], we expect to be able to detect a difference of 1.3 ICU days
between time periods.
JMIR Res Protoc 2019 | vol. 8 | iss. 11 | e16301 | p. 5http://www.researchprotocols.org/2019/11/e16301/
(page number not for citation purposes)
Chang et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Time-Limited Trial Protocol
Physician-led family meetings will be conducted using a
standardized protocol, which includes: (1) introductions, (2)
summary of ICU course, (3) discussion of short- and long-term
prognosis, (4) risks and benefits of aggressive ICU care, and
(5) eliciting patients’ preferences for care during critical illness
and/or at the end of life (see Multimedia Appendix 2 and Figure
1). Based on discussion of these elements, if patients and
surrogate decision makers wish for a palliative approach, the
patient will be transitioned to comfort-focused care. If patients
and surrogate decision makers prefer aggressive ICU care, a
TLT will be performed. For the TLT, care providers and
surrogate decision makers will identify specific clinical
parameters that will be used to determine whether patients are
improving or worsening. Care providers will recommend a time
period for which these parameters will be followed and likely
actions to be taken at the end of the trial based on improvement
or worsening. In the follow-up meeting, care providers will
review trends in clinical parameters; they will also redefine
prognoses based on these trends and additional clinical
information obtained since the last meeting. Based on this
information, recommendations regarding the next steps for care
will be made. If the patients and surrogate decision makers opt
for a palliative approach, comfort-focused care will be provided.
If they prefer continuation of aggressive care, another TLT will
be negotiated. This iterative process will be continued, with
sequential meetings performed at the discretion of the ICU team
(see Figure 1).
Multicomponent Implementation Strategy
Additional components to the implementation strategy are shown
in Figures 1 and 2. ICU physicians—attendings and
fellows—will be trained to use the TLT protocol in educational
sessions utilizing actors as family members in role-playing
scenarios (see Figure 2). Case managers will identify eligible
patients each day by asking ICU physicians which admissions
are ranked priority 3 or 4 and will schedule family meetings
between care providers and patients and their families within
24 hours of admission. Family meetings will be conducted using
checklists to improve compliance with the protocol (see
Multimedia Appendix 2). A standardized electronic health
record (EHR) template will be created to encourage
documentation of important outcomes from meetings and to
facilitate data collection. Each medical ICU will have a
physician champion who will direct implementation of study
protocols at each medical center and conduct monthly feedback
sessions with ICU teams to discuss opportunities for
improvement. Physician champions and research team members
will meet every month to discuss strategies to improve family
meetings, patient enrollment, and data collection.
Outcomes and Measurements
All outcomes will be collected in both the pre- and
postintervention periods. The primary outcome will be ICU
length of stay. Secondary outcomes will include hospital length
of stay, days receiving life-sustaining treatments (eg, mechanical
ventilation, use of vasopressor medications, and renal
replacement therapy), number of attempts at cardiopulmonary
resuscitation (CPR), number of invasive procedures (eg, central
venous or arterial catheterization, thoracentesis, paracentesis,
lumbar puncture, and endoscopy), and outcomes of
hospitalization (eg, death, discharge to hospice, skilled nursing
facility, or home). These data will be collected from
retrospective chart review by trained case managers using
standardized data abstraction forms.
Analysis Plan
Primary and secondary outcomes will be compared before and
after the intervention [46-48]. Days in ICU, days in hospital,
and days receiving life-sustaining treatments will be compared
using Wilcoxon rank-sum tests [49,50]. ICU and hospital
mortality rates will be compared using χ2 tests. Other continuous
and categorical outcomes will be compared between groups
using t tests or χ2 tests, respectively, or equivalent nonparametric
approaches for variables that are nonnormally distributed.
Multivariable regression models will be used to examine the
effects of covariates, such as patient demographics, comorbid
conditions, severity of illness, and hospitals, on study outcomes
[49,50]. Primary and secondary outcomes before and after the
intervention will also be analyzed and will be stratified by ICU
survivors and nonsurvivors. Days receiving ICU care, days
receiving life-sustaining treatments, number of invasive
procedures, and number of CPR attempts among patients who
did not survive hospitalization will be considered nonbeneficial
treatment and will be compared before and after the intervention.
Expected Results
We expect to find fewer ICU days, hospital days, and days of
life-sustaining treatments after the TLT intervention. We also
expect a fewer number of attempts at CPR and other invasive
procedures. We expect mortality rates to remain unchanged
before and after the intervention. We expect reductions in ICU
days, days receiving life-sustaining treatments, and number of
invasive procedures after the intervention to be greater among
patients who died during hospitalization than among survivors.
Limitations
We recognize that priority levels used to identify patients are
subjective. However, we believe that using clinicians’ general
impressions on the likelihood of benefit from ICU care, rather
than more objective measures such as prognostic scoring
systems or predefined lists of medical conditions, emulates
clinical practice and will be more informative regarding the
effectiveness of this intervention. If there are fewer priority 3
and 4 patients than anticipated, we will expand the study criteria
to include patients who were initially categorized into a different
priority level on ICU admission but were assigned priority level
3 or 4 during the ICU hospitalization. Based on our preliminary
data, this will make an additional 10% of ICU patients eligible
for the study.
Ethical Considerations
Our project was approved by the Institutional Review Board
(IRB) at the Los Angeles BioMedical Research Institute at
HUMC (project number: 043544) with approval at the other
two medical centers using a reliance agreement. For Aim 1,
informed consent was obtained for participants in focus groups
and interviews. For Aim 2, the IRB waived the need for
informed consent. There were several key factors involved in
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the waiver of consent. First, communication between ICU
physicians and families is an expected practice; as well, the aim
of the quality-improvement intervention was to encourage
physicians to discuss elements that are vital to effective shared
decision making, such as patient values and preferences,
prognosis, and expectations for ICU treatments. As such, the
intervention posed minimal risk to participants beyond usual
ICU practice. Second, TLTs were not coercive or prescriptive,
and maintained patient and family autonomy in decision making:
at the end of the TLTs, patients and family members could
choose to continue invasive treatments. Third, the
quality-improvement intervention created a new default
communication approach that applied to all ICU patients with
advanced medical illnesses, regardless of participation in the
study. Finally, implementation of the quality-improvement
program was approved by the LAC DHS. Given these factors,
the IRB determined that there was minimal risk to participants,
waiver of consent would not adversely affect the rights and
welfare of the participants, and the project could not be feasibly
performed without the waiver.
Results
The study began in August 2017. The implementation of
interventions and data collection were completed at HUMC and
OVMC. As of September 2019, the study was at the
postintervention stage at the LAC-USC Medical Center. We
have completed focus groups with physicians at each medical
center (N=29) and interviews of family members and surrogate
decision makers (N=18). The study is expected to be completed
in the first quarter of 2020, and results are expected to be
available in mid-2020.
Discussion
Overutilization of ICU treatments among critically ill patients
with advanced medical illnesses leads to medical care that is
invasive, costly, and potentially misaligned with patient
preferences. The successful completion of the aims in this
proposal will improve the quality and efficiency of care by
reducing unnecessary invasive treatments and decreasing ICU
care that does not achieve its intended goals and prolongs
suffering. This will be achieved through better communication
and alignment of ICU care with patients’ values and preferences.
Additionally, these studies will generate preliminary data and
a track record of collaboration between researchers, clinicians,
and hospital leaders, which will be foundational for future
applications that attempt large-scale implementation of
interventions that improve ICU communication and care
planning. Thus, this proposal has the potential to catalyze the
development of an ICU research program that addresses
complex challenges in health care systems; this could be done
through partnerships between academicians in health services
research and frontline physicians and hospital administrators
with experience in operationalizing health care improvements.
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